Alopecia areata and atrophic acne scars are conditions that significantly impact patients' quality of life. Platelet-rich plasma (PRP) therapy has emerged as a promising treatment modality due to its high concentration of growth factors. This study aimed to evaluate the efficacy of PRP in alopecia areata and acne scars. This was a prospective observational study conducted on 50 patients each of alopecia areata and atrophic acne scars treated with intradermal PRP injections at monthly intervals for 6 months. Alopecia areata severity was assessed using a SALT score. Acne scars were graded as per Goodman and Baron's quantitative scar grading system. In alopecia areata patients, the mean SALT score reduced significantly from 35±6 at baseline to 22±3 at 6 months post-treatment (p<0.001). At the study's conclusion, 66% of patients had complete hair regrowth, while 20% had partial and 14% had no regrowth. Higher grade 3 and 4 scars reduced significantly from 86% to 8% (p<0.001). For acne scars, patients with grade 1 scars increased from 0% to 74% after PRP therapy. Mild adverse effects like pain and erythema were seen.PRP therapy showed statistically significant improvement in SALT scores in alopecia areata and acne scar grades over 6 months. It was well-tolerated. PRP can be considered an effective, safe, and economic treatment modality for chronic alopecia areata and atrophic acne scars with sustained benefits.